Prelude Capital Management, LLC Atossa Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $934 Million
- Q2 2025
A detailed history of Prelude Capital Management, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 11,300 shares of ATOS stock, worth $9,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,300Holding current value
$9,492% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ATOS
# of Institutions
87Shares Held
28.6MCall Options Held
12.7KPut Options Held
92.9K-
Black Rock Inc. New York, NY9.2MShares$7.73 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$4.9 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2.97MShares$2.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$1.72 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.81MShares$1.52 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $106M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...